Zobrazeno 1 - 10
of 21
pro vyhledávání: '"ESMO Guidelines Working Group"'
Publikováno v:
Annals of Oncology. 29:iv30-iv40
No abstract available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86177a0c0fea72a629d3a2ebcfa755b6
https://doi.org/10.1093/annonc/mdy133
https://doi.org/10.1093/annonc/mdy133
Autor:
Coleman, R, Body, Jean-Jacques, Aapro, M, Hadji, P, Herrstedt, J., ESMO Guidelines Working Group
Publikováno v:
Annals of oncology, 25 Suppl 3
Coleman, R, Body, J J, Aapro, M, Hadji, P, Herrstedt, J & ESMO Guidelines Working Group 2014, ' Bone health in cancer patients : ESMO Clinical Practice Guidelines ', Annals of Oncology, vol. 25, no. Suppl. 3, pp. iii, 124-37 . https://doi.org/10.1093/annonc/mdu103
Coleman, R, Body, J J, Aapro, M, Hadji, P, Herrstedt, J & ESMO Guidelines Working Group 2014, ' Bone health in cancer patients : ESMO Clinical Practice Guidelines ', Annals of Oncology, vol. 25, no. Suppl. 3, pp. iii, 124-37 . https://doi.org/10.1093/annonc/mdu103
There are three distinct areas of cancer management that make bone health in cancer patients of increasing clinical importance. First, bone metastases are common in many solid tumours, notably those arising from the breast, prostate and lung, as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19661304e99082ec393f14dbc87ee444
https://doi.org/10.1093/annonc/mdu103
https://doi.org/10.1093/annonc/mdu103
Publikováno v:
Annals of Oncology. 23:vii139-vii154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db9b72b4be70105a5e730217b4ebf36
https://doi.org/10.1093/annonc/mds233
https://doi.org/10.1093/annonc/mds233
Publikováno v:
Annals of Oncology. 20:iv105-iv107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7971c0c130c19ed34b967a28f642d79c
https://doi.org/10.1093/annonc/mdp143
https://doi.org/10.1093/annonc/mdp143
Publikováno v:
Annals of Oncology. 21:v214-v219
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F. Pacini, M. G. Castagna, L. Brilli & G. Pentheroudakis On behalf of the ESMO Guidelines Working Group* Section of Endocrinology and Metabolism, Department of I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b65d0b616ba2ff1029bcdf35176338
https://doi.org/10.1093/annonc/mdq190
https://doi.org/10.1093/annonc/mdq190
Autor:
COLOMBO, NICOLETTA, Peiretti, M, Parma, G, Lapresa, M, Mancari, R, Carinelli, S, Sessa, C, Castiglione, M, ESMO Guidelines Working Group
Publikováno v:
Annals of Oncology. 21:v23-v30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c9e2e7fa6b6e93fdb936367bd2b391
https://doi.org/10.1093/annonc/mdq244
https://doi.org/10.1093/annonc/mdq244
Publikováno v:
Öberg, K; Knigge, U; Kwekkeboom, D; Perren, A; ESMO Guidelines, Working Group (2012). Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 23 Suppl 7, vii124-30. Oxford: Oxford University Press 10.1093/annonc/mds295
Annals of Oncology, 23, 124-130. Elsevier Ltd.
Annals of Oncology, 23, 124-130. Elsevier Ltd.
Neuroendocrine gastro-entero-pancreatic tumors : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4077e942bba43bf63c5db4593e862e44
https://pubmed.ncbi.nlm.nih.gov/23493138
https://pubmed.ncbi.nlm.nih.gov/23493138
Publikováno v:
Annals of Oncology, 21, v220-v222. Elsevier Ltd.
The annual incidence of lung neuroendocrine tumour has been reported to be 1.35/100 000/year and the overall age adjusted incidence for thymic carcinoid 0.02/100 000/year. Of all neuroendocrine tumours, ∼25% are located in the respiratory tract. Bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c483578cd18c007d4b7e3edfe1c7d8
http://hdl.handle.net/2318/128622
http://hdl.handle.net/2318/128622
